Oculus Innovative Sciences, Inc. provided revenue guidance for the quarter ending March 31, 2016. For the quarter ending March 31, 2016, the company expects total revenue will be less than $3.8 million due to the weak peso and lower unifying related to the warehouse consolidation in Mexico. Expects the U.S. product revenue will continue to grow in the 50%-plus range for the quarter ending in March.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 USD | +4.88% | -26.00% | +2.55% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.55% | 2.75M | |
+37.81% | 723B | |
+34.28% | 595B | |
-4.46% | 369B | |
+20.07% | 332B | |
+2.73% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.03% | 168B |
- Stock Market
- Equities
- SNOA Stock
- News Sonoma Pharmaceuticals, Inc.
- Oculus Innovative Sciences, Inc. Provides Revenue Guidance for the Quarter Ending March 31, 2016